Interviews

DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.

Why TT Electronics’ good growth continues

TT Electronics plc (LON: TTG) CEO Richard Tyson joins DirectorsTalk to discuss its trading update to the end of October 2019. Richard explains why he is happy with the level..

NQ Minerals Chairman David Lenigas Says he expects to see ‘profitability improving substantially’

NQ Minerals Plc (NEX: NQMI) (OTCQB: NQMLF) new Chairman David Lenigas joins DirectorsTalk to discuss his new role. David explains why he has joined the company, what investors can expect..

Avacta Group partnership with LG Chem goes from strength to strength

Avacta Group (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to update us on the collaboration with LG Chem. Alastair reminds investors of the details behind the collaboration, updates us on..

Why Jubilee Metals Group positive earnings will continue on it’s growth trajectory

Jubilee Metals Group (LON: JLP) CEO Leon Coetzer joins DirectorsTalk to discuss it’s audited results for the year ended 30th June 2019. Leon gives an overview of the results, explains..

Why is Advanced Oncotherapy well positioned for the future?

Advanced Oncotherapy plc (LON: AVO) is the topic of conversation when Dr Martin Hall, Head of Life Sciences at Hardman & Co joins DirectorsTalk. Martin talks us through some interesting..

Morses Club – Interim FY’20 results: steady core, deal upside

Morses Club plc (LON: MCL) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was learnt from the recent results, details on..

Maestrano Acquisition of Airsight leverages new and innovative solutions

Maestrano Group plc (LON: MNO) CEO Andrew Pearson joins DirectorsTalk to discuss the acquisition of Airsight Holdings. Andrew explains the new company business model, provides details on around the acquisition..

ARBUTHNOT BANKING GROUP 3Q19 Trading statement: loans +33%, deposits +17%, investment rising

Arbuthnot Banking Group (LON: ARBB) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was said in the October statement, how new..

Applied Graphene Materials take huge step forward with mainstream product launches

Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss product launches in both Halfords and on Amazon.com. Adrian explains what this means for the company, developments to..

Genedrive – Acceleration of news flow expected

Genedrive plc (LON: GDR) is the topic of conversation when Dr Dorothea Hill joins DirectorsTalk. After releasing a note anticipating accelerated news flow from Genedrive Dorothea gives us an update..

SmartSpace Increased Sales and Demand that’s not slowing down

SmartSpace Software plc (LON: SMRT) CEO Frank Beechinor joins DirectorsTalk to discuss interim results, acquisition and placing. Frank talks us through the interim highlights, provides background and rationale behind the..

Volta Finance 9%+ yield in uncertain times

Volta Finance Limited (LON: VTAS) is the topic of conversation when Mark Thomas joins DirectorsTalk. Mark explains why the report is sat behind a disclaimer, talks us through his note,..

Why Nanoco Group – Leaders in Quantum dot technology are bullish on the future

Nanoco Group plc (LON: NANO) CEO Michael Edelman joins DirectorsTalk to discuss highlights of the financial year end, the new market of IR sensing, the US customer, optimism in the..

Inchcape PLC significant resources for investment or shareholder returns

Inchcape PLC (LON: INCH) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital talks to DirectorsTalk. Mike explains when he has recently published a new..

Avacta plc Major opportunity with Pro-doxorubicin will be the first of many

Avacta plc (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to discuss an agreement with ADC therapeutics. Alastair talks us through the agreement, explains what is expected from AVA6000 pro-doxorubicin in..

Tatton Asset Management Good organic growth & better than market appreciation

Tatton Asset Management (LON: TAM) is the topic of conversation when Robin Savage, Analyst at Zeus Capital joins DirectorsTalk. Robin reminds us of the services the company provides, talks us..

Applied Graphene Materials Commercial momentum continues to build – CEO Interview

Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss its full year results for the year ended 31st July 2019. Adrian explains the highlights for the year,..

Vordere Excited with Brazilian Acquisition

Vordere plc (LON: VOR) CEO Nicholas Hofgren joins DirectorsTalk to discuss its latest acquisition in Brazil. Nicholas runs us through the company business model, explains what the acquisition means for..

Sativa Group take an important step forward with controlled drug licence

Sativa Group (NEX: SATI) CEO Henry Lees-Buckley joins DirectorsTalk to discuss the award of a Controlled Drug Licence from the UK Home Office. Henry explains why this is an important..

Why Metal Tiger could be worth 78% more than current pricing

Metal Tiger plc (LON: MTR) is the topic of conversation when Jason Robertson, Analyst at First Equity joins DirectorsTalk. Jason explains why he’s set a target price of 2.5p per..

Search

Funds

Interviews

Search

Funds

Interviews

FTSE 100

Funds